Introduction
============

Endoscopic resection modalities such as endoscopic mucosa resection (EMR) or endoscopic submucosal dissection (ESD) are now established as the standard treatment modality in the treatment of noninvasive mucosal tumors along the gastrointestinal tract.[@b1-ceg-5-043]--[@b5-ceg-5-043] Especially in flat or nonpedunculated lesions, submucosal injection of normal saline (NS) solution is widely used for separating the lesion from the muscularis propria to allow its resection and prevent perforation and thermal injury to the intestinal wall.[@b6-ceg-5-043]--[@b9-ceg-5-043] However, mucosa elevation is usually seen for only a short period after NS injection, so repeated injections are required. In recent years, several solutions, such as sodium hyaluronate, hydroxypropyl methylcellulose, mannitol, glyceol (G), and fibrinogen, have been investigated and have been shown to extend the duration of mucosal elevation.[@b10-ceg-5-043]--[@b14-ceg-5-043] However, disadvantages such as high costs and difficult administration, as well as concerns about stimulation of tumor cells, have obviated the use of these solutions in routine endoscopy.

The aim of this study was to compare the effectiveness of different components of blood with NS, hyaluronic acid (HA), G, and hydroxyethyl starch (HES) on mucosa elevation after submucosal injection.

Materials and methods
=====================

NS (B Braun Melsungen AG, Melsungen, Germany), 0.125% HA, 0.25% HA, 0.5% HA (Suvenyl^®^, Chugai Pharmaceutical Co, Tokyo, Japan), G (10% glycerin with 0.9% NaCl plus 5% fructose; Chugai Pharmaceutical Co, Tokyo, Japan), and HES 6% (Fresenius Kabi AG, Bad Homburg, Germany), as well as whole blood, plasma, and serum (collected from the corresponding author) were used in this study to create a submucosal fluid cushion. Squares of resected porcine stomach (5 × 5 cm) were stretched on a corkboard. To ensure a constant distance and angle of the specimens relative to a camera, a special construction with fixed camera position and fixed specimen position was used ([Figure 1](#f1-ceg-5-043){ref-type="fig"}). One milliliter of one of the solutions was horizontally injected into the submucosa from the margin of the specimen using a 1 mL syringe with a 23-gauge needle.

Digital pictures were taken before injection, immediately after injection, and every 5 minutes thereafter for up to 60 minutes -- this was controlled by Nikon Camera Control Pro Software (v 1.3.0; Nikon Inc, Melville, NY). Pictures were taken using a Nikon D70S camera with a Nikkor DF Micro 60 mm zoom lens (Nikon Inc). Each experiment was independently repeated five times. The recorded pictures ([Figure 2](#f2-ceg-5-043){ref-type="fig"}) were analyzed in a blinded fashion using Adobe Photoshop (v CS3; Adobe Systems Inc, San Jose, CA), which allowed measurement of mucosa height before and after submucosal fluid injection.

Statistical analysis was performed with a Student's *t*-test using GraphPad Prism (v 5.01; GraphPad Software Inc, La Jolla, CA).

Results
=======

Average mucosa elevation immediately after submucosal injection was between 5.9 and 7.1 mm ([Figure 3](#f3-ceg-5-043){ref-type="fig"}). Submucosa injected with whole blood resulted in a slight but significantly higher mucosa elevation compared with G. However, average mucosa elevation did not differ significantly among the other solutions used in this study ([Figure 3](#f3-ceg-5-043){ref-type="fig"}).

Over time, a decrease of mucosa elevation was observed for all agents used. Significant differences in the duration of elevation could be observed and three distinct groups became evident in terms of the rate of decrease and final height plateau. NS, G, and 0.125% sodium hyaluronate showed the fastest decrease of average mucosa elevation during the observation period, as well as the lowest level of average mucosa elevation after 60 minutes (3.38--3.55 mm), with no significant difference observed between these solutions. In contrast, serum and plasma produced a significantly slower decrease of average mucosa elevation and a significantly higher final plateau (3.95--4.35 mm), which was comparable to HES, 0.25% HA, and 0.5% HA. The slowest decrease of average mucosa elevation and the highest final height plateau (5.23 mm) was observed by using whole blood ([Figures 4](#f4-ceg-5-043){ref-type="fig"} and [5](#f5-ceg-5-043){ref-type="fig"}).

Discussion
==========

Creating a submucosal cushion is a standard method during endoscopic resection of flat or nonpedunculated lesions in the gastrointestinal tract as this reduces the risk of perforation and thermal injury to the gastrointestinal wall. Particularly for the submucosal dissection technique, mucosa elevation by submucosal fluid injection is considered very important for reducing the risk of perforation. Mucosa elevation is most commonly achieved by injecting NS into the submucosa, but the mucosa elevation this generates often decreases quite rapidly due to diffusion into the surrounding tissue. Therefore, different solutions, such as hyperosmolaric dextrose solutions, hydroxypropyl methylcellulose, G, mannitol, and HA, have been extensively investigated for their ability to lengthen the duration of elevation.[@b10-ceg-5-043]--[@b12-ceg-5-043],[@b14-ceg-5-043]--[@b17-ceg-5-043]

Most notably, HA has been shown to create longer-lasting fluid cushions compared with NS both ex vivo and in vivo. However, HA has disadvantages -- namely, its high cost and the conflicting data concerning stimulation of tumor growth, which currently inhibit its general use for submucosal injection.[@b18-ceg-5-043],[@b19-ceg-5-043] Hyperosmolaric solutions are implicated in increasing tissue damage and delaying healing of resection ulcers as well as reducing the quality of resected specimens.[@b20-ceg-5-043] Research has demonstrated a correlation between the duration of mucosal elevation and viscosity, but not osmolarity.[@b14-ceg-5-043] Other agents such as fibrinogen mixtures[@b13-ceg-5-043],[@b14-ceg-5-043],[@b21-ceg-5-043] and poloxamers[@b22-ceg-5-043] can also be used for creating a more durable mucosa elevation. Compared with HA, fibrinogen mixtures and poloxamer solutions are significantly less expensive but remain substantially more expensive than NS. In addition, the use of fibrinogen mixtures for endoscopic resections still needs to be critically considered with regard to their potential to transfer infections.

The present research has demonstrated that duration of mucosa elevation was significantly lengthened by the use of HA at concentrations of 0.5% and 0.25%, as compared with NS, a finding that agrees with other studies. However, the effect of 0.125% HA solutions on mucosa elevation was similar to NS. G, a hypertonic solution consisting of 10% glycerin with 0.9% NS plus 5% fructose, has been discussed as an alternative to HA.[@b15-ceg-5-043] In the current study, the effect of G on mucosal elevation was inferior to HA, to the extent that no difference was observed between G and NS. A previous study also demonstrated the inferiority of G compared with 0.5% and 0.25% HA, but G did show longer-lasting elevation than NS.[@b12-ceg-5-043] In addition, the potential role of HES was investigated and no difference was observed relative to 0.5% and 0.25% HA, serum, or plasma, which is consistent with the results of another recent study.[@b23-ceg-5-043] However, there is some suggestion that HES solutions may exert adverse effects on plasmatic coagulation and platelet function, so these may promote bleeding during or after endoscopic resection.[@b24-ceg-5-043]

The results of the current study suggest that autologous blood and its components may serve as cheap alternatives for achieving a longer-lasting mucosa elevation without risk of transmission of infection. Serum and plasma seem to be as effective as 0.25% and 0.5% HA. However, a problem with the use of plasma or serum in routine endoscopy may be difficulty in rapidly preparing the patient's blood immediately prior to the endoscopic procedure, particularly because this would often need to be performed within the endoscopy unit.

Injection of whole blood gave superior height and duration of submucosa elevation compared with all other solutions tested. Therefore, autologous whole blood might serve as an optimal agent for ESD or EMR procedures that require long-lasting submucosa elevation. However, several questions have to be answered before whole blood is routinely used as a submucosal cushion fluid, as submucosal injection of autologous blood could hamper the specialist's view during the endoscopic resection procedure. Moreover, electrocauterization during endoscopic resection could impair the specialist's vision by introducing burning artifacts. However, dark dyes like methylene blue or toluidine blue are regularly used for submucosal injection without impairing vision during endoscopic resection and a recent study did not observe any impairment of visualization or other technical problems after the submucosal injection of autologous blood prior to endoscopic resection in a porcine model. Furthermore, injection of autologous blood seemed to promote local hemostasis and the clot of the fresh injected blood that formed facilitated the endoscopic resection by separating the muscularis from the submucosal layer of the gastric wall.[@b25-ceg-5-043]

Another disadvantage of using whole blood as a cushion fluid might be blood coagulation. Further studies are required to investigate whether this can be resolved by taking the blood sample immediately before submucosal injection.

Autologous blood is readily available at low cost so may represent an optimal agent for creating the mucosa elevation needed for endoscopic resection. Further in vivo studies in humans are needed to clarify the potential role of autologous blood for long-lasting EMR or ESD.
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![Representative example of overlaid pictures of the gastric wall before, immediately, 5 minutes, and 60 minutes after submucosal fluid injection.](ceg-5-043f2){#f2-ceg-5-043}

![Absolute mucosa elevation immediately after injection of 1 mL solution (average height and standard deviation).M\
**Note:** \**P* \< 0.05.\
**Abbreviations:** NS, normal saline; G, glyceol; HA, hyaluronic acid; HES, hydroxyethyl starch; S, serum; P, plasma; WB, whole blood.](ceg-5-043f3){#f3-ceg-5-043}

![Average absolute mucosa elevation over time after injection of 1 mL solution.\
**Notes:** \**P* \< 0.01; \*\**P* \< 0.0001.\
**Abbreviations:** NS, normal saline; G, glyceol; HA, hyaluronic acid; HES, hydroxyethyl starch; S, serum; P, plasma; WB, whole blood.](ceg-5-043f4){#f4-ceg-5-043}

![Average relative reduction of mucosa elevation over time after injection of 1 mL solution.\
**Abbreviations:** NS, normal saline; G, glyceol; HA, hyaluronic acid; HES, hydroxyethyl starch; S, serum; P, plasma; WB, whole blood.](ceg-5-043f5){#f5-ceg-5-043}
